Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

TEVA-LENOLTEC NO. 3

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TEVA-LENOLTEC NO. 3 in Canada?

Yes. TEVA-LENOLTEC NO. 3 30MG 300MG 15MG has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is TEVA-LENOLTEC NO. 3 not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will TEVA-LENOLTEC NO. 3 be available again?

The manufacturer's estimated resolution date is November 30, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusActive Shortage
Same-ingredient products on fileNone found
Expected resolution~18 days remaining (estimate)
Affected strength30MG 300MG 15MG
Report last updated2026-11-05
Checked by MedShort2026-11-12

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-11-30

~18 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

00653276

Strength

30MG 300MG 15MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

CODEINE PHOSPHATE ACETAMINOPHEN CAFFEINE

Tier

Unrated

Last Updated

2026-11-05

Reason for Shortage

Disruption of the manufacture of the drug.